| Search Bills by: | Bill Quick Search: | Bill Tracking: |
|
All Bills (House | Senate) All Resolutions Subject Short Title Sponsor Date Introduced Code Affected All Same As Pending In Committee Reported From Committee Passed One Chamber Fiscal Notes Completed Legislation Actions by Governor |
| Legislative Session: 2017(RS) | |
| LAST ACTION: | H To House Prevention and Treatment of Substance Abuse 02/08/17 |
| SUMMARY: | Authorizing the medical use of cannabis based pharmaceutical products |
| LEAD SPONSOR: |
Bates |
| SPONSORS: | Ellington, Fleischauer |
|
BILL TEXT:
Bill Definitions |
Introduced Version -
html
| pdf
|
| CODE AFFECTED: |
§16 - 51 - 1
(New Code)
§16 - 51 - 2 (New Code) §16 - 51 - 3 (New Code) §16 - 51 - 4 (New Code) §60A—2—204 (Amended Code) |
| SUBJECT(S): |
Health |
| Description | Date | Journal Page | |
|---|---|---|---|
| H | To House Prevention and Treatment of Substance Abuse | 02/08/17 | 99 |
| H | Introduced in House | 02/08/17 | 99 |
| H | To Prevention and Treatment of Substance Abuse then Health and Human Resources then Judiciary | 02/08/17 | 99 |
| H | Filed for introduction | 02/08/17 | 99 |
Webmaster | © 2025 West Virginia Legislature **
